Civica Rx, the hospital-run, not-for-profit company created to supply hospitals with generic drugs, announced this week that Xellia Pharmaceuticals will supply the company with two antibiotics, vancomycin and daptomycin. Civica says it will deliver 14 generic medications to hospitals by the end of this year.
Eventually, the company plans to buy or build is own manufacturing facilities. But to get off the ground, Civica is contracting with the holders of abbreviated new drug applications, according to Modern Healthcare.
Xellia is headquartered in Copenhagen but is expanding its U.S. manufacturing, according to Civica's announcement of the deal this week.
Civica was established in 2018 to alleviate drug shortages. Martin VanTrieste, former chief quality officer of Amgen, is the CEO.